Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0

Mikra partners with global leader in NutraBiosciences® to release CELLF 2.0 featuring improved flavor and consistency thanks to Virun’s patented technology

ORONTO, May 09, 2024 (GLOBE NEWSWIRE) -- Lifeist Wellness Inc. (“Lifeist” or the “Company”) (TSXV: LFST) (FRANKFURT: M5B) (OTCMKTS: LFSWF), a health-tech company that leverages advancements in science and technology to build breakthrough ventures that transform human wellness, is pleased to announce that its U.S. biosciences subsidiary Mikra Cellular Sciences Inc. (“Mikra”) has partnered with Virun NutraBiosciences Inc. (“Virun”), the global leader in NutraBiosciences®1, to offer CELLF 2.0, an enhanced nutraceutical gel for improving cellular health. CELLF 2.0 is available for sale now and can be ordered directly at http://wearemikra.com/products/cellf.

“We are so excited to partner exclusively with Mikra and their CELLF brand containing Glutathione, PQQ and CoQ10. Our patents and patents-pending technologies are a perfect fit for Mikra. The anti-aging, mitochondrial biogenesis benefits of CELLF 2.0 are unrivaled,” said Philip Bromley, CEO of Virun NutraBiosciences Inc.

Read the rest of the story here or a PDF version here. To read the news published by Virun on their blog, click here.

Shared by Steve Kirby, board member of Virun, Inc.